<DOC>
	<DOCNO>NCT01889966</DOCNO>
	<brief_summary>Sildenafil selective pulmonary vasodilator ; patient special kind pulmonary hypertension approve treatment . The trial seek find , whether acute response treatment ( = vasoreactivity test ) give intravenously effective allows prediction therapy success follow oral treatment .</brief_summary>
	<brief_title>VasoREACTivity Testing With Intravenous SILdenafil Patients With Precapillary Pulmonary Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Connective Tissue Diseases</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Precapillary pulmonary hypertension associate connective tissue disease rest mean pressure pulmonary artery &gt; 24 mmHg rest mean pulmonary capillary wedge pressure ( PCWP ) &lt; 16 mmHg age 18 80 year woman childbearing potential must negative pregnancy test ( ßHCG urine ) must use effective method contraception woman must breastfeed ability understand sign inform consent , correctly sign inform consent pretreatment Sildenafil contraindication Sildenafil treatment : know intolerance Sildenafil , optic neuropathy ( NAION ) , know hereditary retina disease , need nitrate therapy advance liver cirrhosis CHILD C severely reduce renal function GFR &lt; 30 ml/min/1,73 m² stroke myocardial infarction within last 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>vasoreactivity test</keyword>
	<keyword>Sildenafil</keyword>
	<keyword>precapillary pulmonary hypertension</keyword>
	<keyword>connective tissue disease</keyword>
	<keyword>mean pressure pulmonary artery 25 mmHg</keyword>
	<keyword>mean pulmonary capillary wedge pressure 16 mmHg</keyword>
</DOC>